Author:
Walz Amy L.,Fernandez Conrad V.,Geller James I.
Publisher
Springer Science and Business Media LLC
Reference119 articles.
1. Comprehensive update of pediatric renal tumor epidemiology: analysis of the first 4000 patients on Children's Oncology Group (COG) renal tumor classification and biology protocol AREN03B2 (2014). Pediatr Blood Cancer https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.25314. Accessed 10/22/2019.
2. Dix, D. B., Fernandez, C. V., Chi, Y. Y., Mullen, E. A., Geller, J. I., Gratias, E. J., et al. (2019). Augmentation of therapy for combined loss of heterozygosity 1p and 16q in favorable histology Wilms tumor: a Children's Oncology Group AREN0532 and AREN0533 study report. J Clin Oncol, 37(30), 2769–2777. https://doi.org/10.1200/jco.18.01972.
3. Fernandez, C. V., Mullen, E. A., Chi, Y. Y., Ehrlich, P. F., Perlman, E. J., Kalapurakal, J. A., Khanna, G., Paulino, A. C., Hamilton, T. E., Gow, K. W., Tochner, Z., Hoffer, F. A., Withycombe, J. S., Shamberger, R. C., Kim, Y., Geller, J. I., Anderson, J. R., Grundy, P. E., & Dome, J. S. (2018). Outcome and prognostic factors in stage III favorable-histology Wilms tumor: a report from the Children's Oncology Group study AREN0532. J Clin Oncol, 36(3), 254–261. https://doi.org/10.1200/jco.2017.73.7999.
4. Dix, D. B., Seibel, N. L., Chi, Y. Y., Khanna, G., Gratias, E., Anderson, J. R., et al. (2018). Treatment of stage IV favorable histology Wilms tumor with lung metastases: a report from the Children's Oncology Group AREN0533 Study. J Clin Oncol, 36(16), 1564–1570. https://doi.org/10.1200/jco.2017.77.1931.
5. Pritchard-Jones, K., Bergeron, C., de Camargo, B., van den Heuvel-Eibrink, M. M., Acha, T., Godzinski, J., et al. (2015). Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial. Lancet, 386(9999), 1156–1164. https://doi.org/10.1016/s0140-6736(14)62395-3.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献